Quarter Period Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7609939

Concept 2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
109,717,000 JPY
89,688,000 JPY
Cost of sales
7,001,000 JPY
3,916,000 JPY
Gross profit (loss)
102,715,000 JPY
85,771,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
140,706,000 JPY
136,576,000 JPY
Operating profit (loss)
-37,991,000 JPY
-50,805,000 JPY
Non-operating income
Interest income
13,000 JPY
9,000 JPY
Non-operating income
12,794,000 JPY
11,190,000 JPY
Non-operating expenses
Interest expenses
886,000 JPY
1,216,000 JPY
Non-operating expenses
910,000 JPY
1,330,000 JPY
Ordinary profit (loss)
-26,107,000 JPY
-40,944,000 JPY
Profit (loss) before income taxes
-26,107,000 JPY
-40,944,000 JPY
Income taxes - current
398,000 JPY
398,000 JPY
Income taxes
398,000 JPY
398,000 JPY
Profit (loss)
-26,506,000 JPY
-41,343,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
-4,644,000 JPY
JPY
Profit (loss) attributable to owners of parent
-21,861,000 JPY
-41,343,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-569,000 JPY
JPY
Other comprehensive income
-569,000 JPY
JPY
Comprehensive income
-27,075,000 JPY
-41,343,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-22,431,000 JPY
-41,343,000 JPY
Comprehensive income attributable to non-controlling interests
-4,644,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.